Erik R Swenson. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » 3',5'-Cyclic-GMP Phosphodiesterases/drug effectsAltitude Sickness/physiopathologyAltitude Sickness/prevention & controlCyclic Nucleotide Phosphodiesterases, Type 5Dexamethasone/therapeutic useHumansPhosphodiesterase Inhibitors/therapeutic usePulmonary Edema/physiopathologyPulmonary Edema/prevention & controlVasodilator Agents/therapeutic use
Substances： See more » Phosphodiesterase InhibitorsVasodilator AgentsDexamethasone3',5'-Cyclic-GMP PhosphodiesterasesCyclic Nucleotide Phosphodiesterases, Type 5PDE5A protein, human
Year: 2006 PMID： 17015875 DOI： 10.7326/0003-4819-145-7-200610030-00015
Source DB: PubMed Journal: Ann Intern Med ISSN： 0003-4819 Impact factor: 25.391